The U.S. is trying to transform a vast, mature, deeply entrenched healthcare system. Much of the Gulf is building newer systems from a far cleaner slate. In this episode, Dr. M. Ayoub Ashraf — who has worked in both — argues that one region is retrofitting and the other is rebuilding, and that single difference changes almost everything about what's possible.

He covers three things. First, the weight of a mature system: inertia where every inefficiency is somebody's job and every excess cost is somebody's revenue, the challenge of rewiring a system while it runs (like replacing an aircraft engine mid-flight), and the weight of expectation that can make an economically sensible reform politically impossible. Second, the Gulf's cleaner slate — national, top-down strategy that can move faster, a younger population with a closing window to design for prevention, and the freedom to build modern, digital-first models from the start — alongside real constraints, from workforce dependence to the fact that designing a system quickly isn't the same as embedding it deeply. And third, what each can genuinely learn from the other: the most valuable thing America offers the Gulf isn't its successes but its scar tissue — 50 years of knowing exactly what happens when you pay for volume — while the U.S. can relearn what becomes possible when transformation is coordinated and bold.

Retrofit and rebuild are two different disciplines that reward different kinds of leaders — and the ones who can move between them will shape the next era of global healthcare.

— Dr. M. Ayoub Ashraf is a physician by training, healthcare strategist, and consultant (MD, MBA, MPH, CPC, CPMA, FACHE). Follow HealtheNomics for more on the economics and strategy of healthcare.

🌐 More at healthenomics.com

A surprising amount of what frustrates people about healthcare — the denials, the prior authorizations, the surprise bills — flows from a single hidden tension. In this episode, Dr. M. Ayoub Ashraf explains the relationship between payers and providers, and why two groups serving the same patients have historically been pulled in opposite directions.

He covers three things. First, the two different jobs — the payer stewarding a finite pool of money across a whole population (the one who has to say no on everyone's behalf), and the provider trained and paid to act for the individual in front of them — and why neither side is actually wrong. Second, where they collide: prior authorization, denials and appeals, and contract negotiations, plus the uncomfortable cost of the argument itself — by one Annals of Internal Medicine estimate, U.S. health administration ran to roughly $812 billion, about a third of national health spending, with far more admin staff and physician hours lost to paperwork than in Canada. And third, how the relationship is changing — shared risk that makes providers start to think like payers, vertical integration as payers buy providers and providers launch their own plans, and the automation of the argument, which makes the fight cheaper without making it unnecessary.

The real fix isn't a faster prior authorization — it's a payment model where the prior authorization was never needed in the first place.

— Dr. M. Ayoub Ashraf is a physician by training, healthcare strategist, and consultant (MD, MBA, MPH, CPC, CPMA, FACHE). Follow HealtheNomics for more on the economics and strategy of healthcare.

🌐 More at healthenomics.com

We all agree that keeping people healthy is the goal — so why does the healthcare system consistently underfund it? In this episode, Dr. M. Ayoub Ashraf unpacks one of the great contradictions in healthcare: the problem was never that we don't believe in prevention — it's that the economics of prevention are far harder than the idea of prevention.

He covers three things. First, what population health actually means — being accountable for an entire group, including the patient who never walks through your door, and why as much as 80% of what determines health happens outside the hospital. Second, why the money doesn't flow to prevention even when the evidence supports it: the timing problem (costs now, benefits decades away), the wrong-pocket problem (the pocket that pays isn't the pocket that profits), the volume problem (fee-for-service pays more when people stay sick), and the fact that prevention has no constituency — the heart attack that never happened has no face. And third, what's beginning to change — risk-bearing models, funding social needs like housing and transport, and data that finds the people whose payback is measured in months, not decades — with an honest caution that the pace is slower than the conference stage suggests.

The throughline: a system that profits from illness can never be as strong as one that profits from health.

— Dr. M. Ayoub Ashraf is a physician by training, healthcare strategist, and consultant (MD, MBA, MPH, CPC, CPMA, FACHE). Follow HealtheNomics for more on the economics and strategy of healthcare.

🌐 More at healthenomics.com